IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0034101.html
   My bibliography  Save this article

The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model

Author

Listed:
  • Bruno Ventelou
  • Yves Arrighi
  • Robert Greener
  • Erik Lamontagne
  • Patrizia Carrieri
  • Jean-Paul Moatti

Abstract

Aim: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries. Methods: We used a micro-simulation model based on individuals aged 15–49 selected from nationally representative surveys (DHS for Cameroon, Tanzania and Swaziland) to compare alternative scenarios : 1-freezing of ART programs to current levels of access, 2- universal access (scaling up to 100% coverage by 2015, with two variants defining ART eligibility according to previous or current WHO guidelines). We introduced an “artificial” ageing process by programming methods. Individuals could evolve through different health states: HIV negative, HIV positive (with different stages of the syndrome). Scenarios of ART procurement determine this dynamics. The macroeconomic impact is obtained using sample weights that take into account the resulting age-structure of the population in each scenario and modeling of the consequences on total growth of the economy. Results: Increased levels of ART coverage result in decreasing HIV incidence and related mortality. Universal access to ART has a positive impact on workers' productivity; the evaluations performed for Swaziland and Cameroon show that universal access would imply net cost-savings at the scale of the society, when the full macroeconomic consequences are introduced in the calculations. In Tanzania, ART access programs imply a net cost for the economy, but 70% of costs are covered by GDP gains at the 2034 horizon, even in the extended coverage option promoted by WHO guidelines initiating ART at levels of 350 cc/mm3 CD4 cell counts. Conclusion: Universal Access ART scaling-up strategies, which are more costly in the short term, remain the best economic choice in the long term. Renouncing or significantly delaying the achievement of this goal, due to “legitimate” short term budgetary constraints would be a misguided choice.

Suggested Citation

  • Bruno Ventelou & Yves Arrighi & Robert Greener & Erik Lamontagne & Patrizia Carrieri & Jean-Paul Moatti, 2012. "The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-12, April.
  • Handle: RePEc:plo:pone00:0034101
    DOI: 10.1371/journal.pone.0034101
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0034101
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0034101&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0034101?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Rochelle P Walensky & Robin Wood & Andrea L Ciaranello & A David Paltiel & Sarah B Lorenzana & Xavier Anglaret & Adam W Stoler & Kenneth A Freedberg & for the CEPAC-International Investigators, 2010. "Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis," PLOS Medicine, Public Library of Science, vol. 7(12), pages 1-12, December.
    2. John Stover & Eline L Korenromp & Matthew Blakley & Ryuichi Komatsu & Kirsi Viisainen & Lori Bollinger & Rifat Atun, 2011. "Long-Term Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy," PLOS ONE, Public Library of Science, vol. 6(6), pages 1-7, June.
    3. Clive Bell & Shantayanan Devarajan & Hans Gersbach, 2006. "The Long-Run Economic Costs of aids: A Model with an Application to South Africa," The World Bank Economic Review, World Bank, vol. 20(1), pages 55-89.
    4. Stephen Resch & Eline Korenromp & John Stover & Matthew Blakley & Carleigh Krubiner & Kira Thorien & Robert Hecht & Rifat Atun, 2011. "Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-9, October.
    5. Alwyn Young, 2005. "The Gift of the Dying: The Tragedy of AIDS and the Welfare of Future African Generations," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 120(2), pages 423-466.
    6. Sara Bennett & Sachiko Ozawa & Krishna D Rao, 2010. "Which Path to Universal Health Coverage? Perspectives on the World Health Report 2010," PLOS Medicine, Public Library of Science, vol. 7(11), pages 1-3, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Xuanlong Qin & Danish Iqbal Godil & Muhammad Kamran Khan & Salman Sarwat & Sadaf Alam & Laeeq Janjua, 2022. "Investigating the effects of COVID-19 and public health expenditure on global supply chain operations: an empirical study," Operations Management Research, Springer, vol. 15(1), pages 195-207, June.
    2. Yves Arrighi & Mohammad Abu‐Zaineh & Bruno Ventelou, 2015. "To Count or Not to Count Deaths: Reranking Effects in Health Distribution Evaluation," Health Economics, John Wiley & Sons, Ltd., vol. 24(2), pages 193-205, February.
    3. Amiri, Arshia & Ventelou, Bruno, 2012. "Granger causality between total expenditure on health and GDP in OECD: Evidence from the Toda–Yamamoto approach," Economics Letters, Elsevier, vol. 116(3), pages 541-544.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sanghamitra Das & Abhiroop Mukhopadhyay & Tridip Ray, 2008. "Negative reality of the HIV positives: Evaluating welfare loss in a low prevalence country," Discussion Papers 08-02, Indian Statistical Institute, Delhi.
    2. Maik T. Schneider & Ralph Winkler, 2021. "Growth and Welfare under Endogenous Lifetimes," Scandinavian Journal of Economics, Wiley Blackwell, vol. 123(4), pages 1339-1384, October.
    3. Boucekkine, Raouf & Laffargue, Jean-Pierre, 2010. "On the distributional consequences of epidemics," Journal of Economic Dynamics and Control, Elsevier, vol. 34(2), pages 231-245, February.
    4. Rui Huang & Lilyan E. Fulginiti & E. Wesley F. Peterson, 2010. "Health and growth: causality through education," China Agricultural Economic Review, Emerald Group Publishing Limited, vol. 2(3), pages 321-344, September.
    5. Kathleen Beegle & Joachim De Weerdt & Stefan Dercon, 2008. "Adult Mortality and Consumption Growth in the Age of HIV/AIDS," Economic Development and Cultural Change, University of Chicago Press, vol. 56(2), pages 299-326, January.
    6. Bell, Clive & Gersbach, Hans, 2013. "Growth and enduring epidemic diseases," Journal of Economic Dynamics and Control, Elsevier, vol. 37(10), pages 2083-2103.
    7. Chinhui Juhn & Sebnem Kalemli-Ozcan & Belgi Turan, 2013. "HIV and fertility in Africa: first evidence from population-based surveys," Journal of Population Economics, Springer;European Society for Population Economics, vol. 26(3), pages 835-853, July.
    8. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
    9. Martin Karlsson & Stefan Pichler, 2015. "Demographic consequences of HIV," Journal of Population Economics, Springer;European Society for Population Economics, vol. 28(4), pages 1097-1135, October.
    10. Rodolfo Manuelli & Emircan Yurdagul, 2021. "AIDS, Human Capital and Development," Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 42, pages 178-193, October.
    11. Vasilakis, Chrysovalantis, 2012. "The social economic impact of AIDS: Accounting for intergenerational transmission, productivity and fertility," Economic Modelling, Elsevier, vol. 29(2), pages 369-381.
    12. Bell, Clive & Gersbach, Hans, 2009. "The macroeconomics of targeting: the case of an enduring epidemic," Journal of Health Economics, Elsevier, vol. 28(1), pages 54-72, January.
    13. Pedro Cavalcanti Ferreira & Samuel Pessôa & Marcelo Rodrigues Dos Santos, 2011. "The Impact Of Aids On Income And Human Capital," Economic Inquiry, Western Economic Association International, vol. 49(4), pages 1104-1116, October.
    14. Francesco Strobbe & Claudia Olivetti & Mireille Jacobson, 2010. "Breaking the Net: Family Structure and Street Children in Zambia," Global Development Institute Working Paper Series 11110, GDI, The University of Manchester.
    15. Jensen, Henning Tarp & Keogh-Brown, Marcus & Smith, Richard & Bretcher, Michael & Chico, Matthew, 2013. "Malaria in Ghana: Integrated Macroeconomic and Epidemiological-Demographic Impact Assessment," Conference papers 332397, Purdue University, Center for Global Trade Analysis, Global Trade Analysis Project.
    16. Da Costa, Shaun, 2023. "Estimating the welfare gains from anti-retroviral therapy in Sub-Saharan Africa," Journal of Health Economics, Elsevier, vol. 90(C).
    17. Bell, Clive & Bruhns, Ramona & Gersbach, Hans, 2006. "Economic growth, education, and AIDS in Kenya : a long-run analysis," Policy Research Working Paper Series 4025, The World Bank.
    18. Béland, Louis-Philippe & Brodeur, Abel & Wright, Taylor, 2020. "The Short-Term Economic Consequences of COVID-19: Exposure to Disease, Remote Work and Government Response," GLO Discussion Paper Series 524, Global Labor Organization (GLO).
    19. Chicoine, Luke, 2012. "AIDS mortality and its effect on the labor market: Evidence from South Africa," Journal of Development Economics, Elsevier, vol. 98(2), pages 256-269.
    20. Johansson, Lars M., 2007. "Fiscal implications of AIDS in South Africa," European Economic Review, Elsevier, vol. 51(7), pages 1614-1640, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0034101. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.